chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient had M.I. No known history of illness. Received records from county health department with no new info. 7/13/06 Received old medical records from prior hospital visits which reveal patient was a smoker & had hx of back pain.  Chest pain dx as costochondritis & also intermittent atrial fibrillation.  Cardiac enzymes were neg. 8/18/06 Received ER medical records which revealed patient had been found by family member & had been down for approx 45 min prior to arrival in ER.  Was in full arrest upon arrival & resuscitation was unsuccessful. 8/18/06 Received Death Certificate which revealed COD as acute MI/ss
About 24 hrs after vaccine, site (Lt thigh) noted to be red and warm. Brought to office 7/12/13 - area around vaccine site red - 5 cm x 6 cm. Additional 3x4 cm area of redness noted Lt. lower abd - treated with antibiotics.
4 hours after injection felt very sleepy, following day had chills, fever, and headache. 18th had severe charley horses in leg. 21st went to urgent care, md thought gout and was given steroid injection. 24th still in severe pain, went to hospital and diagnosed with dvt.
Numbness; Tingling; Rash on the same arm; Underarm swollen lymph node; A little sick and felt a little fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE HYPOAESTHESIA (Numbness), VACCINATION SITE PARAESTHESIA (Tingling), VACCINATION SITE RASH (Rash on the same arm), LYMPHADENOPATHY (Underarm swollen lymph node) and FATIGUE (A little sick and felt a little fatigue) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jan-2021, the patient experienced FATIGUE (A little sick and felt a little fatigue). On 08-Jan-2021, the patient experienced LYMPHADENOPATHY (Underarm swollen lymph node). On 14-Jan-2021, the patient experienced VACCINATION SITE HYPOAESTHESIA (Numbness), VACCINATION SITE PARAESTHESIA (Tingling) and VACCINATION SITE RASH (Rash on the same arm). On 11-Jan-2021, LYMPHADENOPATHY (Underarm swollen lymph node) had resolved. At the time of the report, VACCINATION SITE HYPOAESTHESIA (Numbness), VACCINATION SITE PARAESTHESIA (Tingling) and VACCINATION SITE RASH (Rash on the same arm) had not resolved and FATIGUE (A little sick and felt a little fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant details not reported by the reporter. Treatment details not reported by the reporter.
3/28/2021   patient was observed post Covid-19 immunization for 45 minutes .  During the observation period, he experienced an adverse reaction with the following symptoms:  Tingling around the face and mouth and down the vaccinated left arm..   Assessment : Time of assessment 1138 Alert and oriented.   Actions taken:  Observation 45 minutes, Vs - BP- 132/99. P- 68, O2- 100%        Medications administered: No medication administered.   Disposition: Reports no further symptoms of adverse reaction after observation for 45 minutes. Discharged home.     Immunizations Administered    Name Date Dose VIS Date Route   Pfizer COVID-19 Vaccine 3/28/2021 10:48 AM 0.3 mL 12/11/2020 Intramuscular   Manufacturer: Pfizer, Inc   Lot: ER8733
sever swelling at injection site; This is a spontaneous report from a contactable Nurse via Pfizer sales representative. This Nurse reported similar event for 3 patient. This is 1st of three reports.   A patient of unspecified age and gender started to receive meningococcal group b rlp2086 (TRUMENBA) , via an unspecified route of administration on an unspecified date at single dose for immunisation in the arm, meningococcal vaccine a/c/y/w conj (dip tox) (MENACTRA) , via an unspecified route of administration on  an unspecified date at single dose for immunisation in the same arm.  The patient medical history and  concomitant medications were not reported.  The patient experienced sever swelling at injection site  on an unspecified date with outcome of unknown.  The reported event was considered non serious.  No follow-up attempts are possible, information about batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2019352013 same reporter/ drug/ AE, different patient.
No additional AEs; When the product was received it was supposed to be returned to the wholesaler, instead they were placed in the refrigerator. It was discovered yesterday that 5 bad doses were given, and 6 potential patients were involved.; 5 bad doses were given, and 6 potential patients were involved; back in April we had a delivery of GARDASIL 9 that did not arrive for more than 5 days; This spontaneous report was received from an office manager referring to a patient of unknown age and gender.  Information about the patient's pertinent medical history, concurrent conditions, concomitant medications and previous drug reactions or allergies was not provided.  On an unspecified date in April 2021, the reporter had a delivery of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) that did not arrive for more than 5 days (product distribution issue), when the product was received it was supposed to be returned to the wholesaler, instead it was placed in the refrigerator (product storage error). Information about the temperature storage or a time frame was unknown by the reporter. There wasn't a previous temperature excursion.  On 13-MAY-2021, the patient was vaccinated with a bad dose HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) (poor quality product administered) pre-filled syringe, 1 time dose as prophylaxis (dose, route of administration, anatomical location and vaccine scheme were not reported; lot number T026168 has been verified to be valid, expiration date reported and validated as 04-DEC-2022) as prophylaxis. No additional adverse events occurred.  This is one of several reports received from the same reporter. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: T026168; expirationdate: 04-DEC-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet criteria for reportability; Sender's Comments:  US-009507513-2106USA005001: US-009507513-2106USA005005: US-009507513-2106USA005150: US-009507513-2106USA005047: US-009507513-2106USA005081:
Numb Tongue/Tip of the tongue still numb; Jittery; Numb Face with tingling; Flushing; Chest pain; Heart was fast; Shortness of breath/Hard time breathing; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA ORAL (Numb Tongue/Tip of the tongue still numb), FEELING JITTERY (Jittery), HYPOAESTHESIA (Numb Face with tingling), FLUSHING (Flushing) and CHEST PAIN (Chest pain) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939902) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Aug-2021, the patient experienced HYPOAESTHESIA ORAL (Numb Tongue/Tip of the tongue still numb), FEELING JITTERY (Jittery), HYPOAESTHESIA (Numb Face with tingling), FLUSHING (Flushing), CHEST PAIN (Chest pain), HEART RATE INCREASED (Heart was fast) and DYSPNOEA (Shortness of breath/Hard time breathing). At the time of the report, HYPOAESTHESIA ORAL (Numb Tongue/Tip of the tongue still numb), FEELING JITTERY (Jittery), HYPOAESTHESIA (Numb Face with tingling), FLUSHING (Flushing), CHEST PAIN (Chest pain), HEART RATE INCREASED (Heart was fast) and DYSPNOEA (Shortness of breath/Hard time breathing) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Aug-2021, Heart rate: fast fast.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   After the shot the patient waited more than 15 minutes and within 30 minutes felt a numb tongue, jittery, numb face with tingling, flushing, chest pain, her heart was fast, shortness of breath/hard time breathing for about 6 hours. But the tip of tongue was still numb since then. No Concomitant medications were provided. No treatment medications were provided.
weakness; diarrhea; Dizziness; Really Bad Tiredness; Swollen lymph nodes; This is a spontaneous report from a contactable consumer (patient's wife). A 77-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration at 77-year-old on 11Mar2021 12:00 (lot number: EN6199) at single dose for COVID-19 immunization. Vaccine was received in pharmacy, not at military facility. The patient medical history was reported as none. Family medical history relevant to the events was none. The patient's concomitant medications were not reported. No history of all previous immunization with the BNT162B2 considered as suspect. No additional vaccines were administered on same date of BNT162B2. No other products. No prior vaccinations within 4 weeks. No events following prior vaccinations. The patient experienced diarrhea (hospitalization) on 18Mar2021, weakness (hospitalization) on 22Mar2021, swollen lymph nodes on 18Mar2021, really bad tiredness on 19Mar2021, dizziness on 26Mar2021. Dizziness occurred when he stood up. The patient was hospitalized for diarrhea and weakness from 22Mar2021 to 24Mar2021. The patient was getting weak and they got worried and went to the ER (Emergency Room); he was admitted on 22Mar2021, observed on 23Mar2021 and came out on 24Mar2021. He was "Out of It" and on that Monday he was feeling so tired and weak and he had problems all last year and they were alarmed so they went to be checked out and the patient was released without finding anything. The events resulted in emergency room visit on 22Mar2021. No visit to physician office. Therapeutic measures were taken as a result of events included loperamide hydrochloride (IMODIUM). The outcome of events diarrhea, weakness, swollen lymph nodes, really bad tiredness was recovering, outcome of event dizziness was recovered on 26Mar2021. No medications, medical conditions, or tests relevant to this report. Consumer mentioned that the patient has an appointment to get the second dose of the BNT162B2 on 01Apr2021 and wanted to know if there were reports about getting the second dose will make the side effects stronger.
Client began w/red, prickly "heat" rash on her neck 2/9/14 9:00 AM. No whelps, blisters, etc. Rash described as confluent. Covered her body from her ears to her toes. Intense itching. Mild fever PM of 2/9/14. Parent began BENADRYL x 2 every 4 hours until 9:00 AM on 2/10/14. Itching has started to resolve. Rash is not as dark as it was 24 hours ago. Also tried CALADRYL LOTION and oatmeal baths to help w/itching. No hives. No SOB.
Breakthrough case admission after 4 vaccines Moderna 2/6/21 Lot# 031L20A;  Moderna 3/6/21 Lot# 032M20A;  Moderna 11/11/21 Lot# 034F21A;  Moderna 11/1/22 Lot# 062F22A
Patient received pfizer vaccine on 1/13/21, 2/4/21 and 6/1/22. Presented to ER on 7/9/22. COVID positive on 6/25/22. Patient presented to ED with chest pain.  Patient report he was in the emergency room yesterday with chest pain and then discharge home. He reports he is not a candidate for heart surgery and has been being managed medically.    He presented to ED for not getting comfort with chest pain today afternoon.  During examination patient reports he does not have any complaints and all his symptoms have resolved. Afore mentioned pt is admitted for 1. Sepsis(elevated wbc/procal/lactic acidosis and source of infection) probably due to acute cholecystitis and UTI/proteus in urine. No growth in blood cultures. Continued  With rocephin. WBC trended down. Pt became medically stable after percutaneous closest started me tube. Patient was COVID asymptomatic. Discharged on 7/18/22
Nurse states vaccine leaked from patient's left arm during ID administration; patient did not receive a full dose.  Same nurse repeated ID administration on the same arm (left arm) successfully. No patient complications noted.
After receiving Tdap and MENACTRA child fainted. BP 100/70. Drank juice 8 oz. Then became grey, sweaty. BP not audible, radial pulse not palpable. 911 called. Given another 8oz of juice, granola bar. BP came up to 110/70, blood sugar 79. Went to ER for evaluation. No problems breathing. Alert and oriented throughout.
Woke up with sharp , severe, epigastric pain  - stabbing. Felt like someone was stabbing. It was at 2:22 am, day after vaccination, 12/31. Pain lasted for 30 minutes. Took Tylenol - pain subsided after 20 minutes.  Took temp at 2:22 am, was normal at the time. When woke up at 7 am, temp was 103.1.  Lowest temp over the last 12 hours was 99.9.
Fever - 100.4 (Tylenol), achy all over, sore throat, injection site warm and sore, trouble sleeping, headache
MIGRAINE; BODY ACHES; FATIGUE; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, batch number: UNKNOWN) dose was not reported, administered on 31-MAR-2021 for prophylactic vaccination. The batch number was not reported. the company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 01-APR-2021, the subject experienced migraine. On 01-APR-2021, the subject experienced body aches. On 01-APR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the migraine, body aches and fatigue was not reported. This report was non-serious.
This spontaneous report was received from a registered nurse, refers to an unknown number of patients, of an unknown age and gender. Medical history and concurrent conditions were not reported. The register nurse informed that on an unknown date, the patients were vaccinated with RECOMBIVAX HB (strength, dosage, route, lot# and expiration date were not reported). That had been improperly stored. No adverse effects were reported. This is one of several cases received from the same reporter. Additional information is not expected because the physician refused to be contacted.
Patient reported sores blisters on roof of mouth and under tongue and a sore throat 2 days after having shingles shot. Patient was seen at Dr's office and released on day 3 with diagnosis of viral infection in mouth/unrelated to ZOSTAVAX.
About 1.5 hour after the injection, my left thumb pad swelled up and started feeling itchy.  It became uncomfortable like I had a blood pressure cuff around the joint.  Soon I could see the beginnings of a bruise forming around the perimeter of the swollen area.  It turned red/purple throughout the evening and spread over half of the area.  By the next morning, much of the swelling had gone away but the bruise remained, in fact it had spread to the other (nail) side of the thumb.  My doctor suspects a vascular reaction to the shot, similar to Covid Toes only in my thumb instead.
11/15/06 Patient presented today with complains of unable to lift right arm at times. Has moved to left arm also. Complain of pain left arm also. No redness, hardness noted upon examination. I lifted arm without complains of voided by patient. Right arm warm and dry. No numbness can feel stimulation.
Information has been received from a health care professional concerning a 10 year old male who in 1995 was vaccinated with a dose of varicella virus vaccine, live. On 06/16/04 the pt presented with chickenpox. The Sx included 50-75 vesicular lesions, a fever of 101.2 F, and a sore throat. Tx included oral and ocular antibiotics. Follow up information from the nurse indicated that the pt did not have chicken pox. The child had adenovirus. No product quality complaint was involved. Additional information has been requested.
Patient was due for the HIB vaccine, but when pulling the vaccines from the fridge, a combination vaccine that had HIB in it as well as DTAP, and IPV was pulled instead of a single dose of HIB being pulled. Patient received 2 doses of DTAP and IPV since he was given another vaccine with both of those as well.  Patient mother was notified of the error and reports that patient has not had any reactions and seems completely fine at this point. No treatment necessary at this time
symptoms onset was 6:53 pm noted, increased redness of face and eyes, rash on fax and arms, increased heart palpitation. BP 140/80, HR 140 bpm, at 6:55 pm. patient complaining feeling nervous and warm. BP retake at 7:00 pm 130/82, heart rate 120, rash decreased, patient denied shortness of breath or palpitations. EMS on site provided support, patient refused EMT care or hospital transfer. Patient was administered 10 ml Benadryl liquid on site. Responsive and established and observed for 1/2 hour. Patient stated having had history of general allergies.  Patient discharged at 7:42 pm in well condition accompanied by relative.
Vomiting, headache, severe dizziness, ear pain, tinnitus, jaw pain, blood sugars uncontrolled, sore throat, itchy on palms and soles and ended up with inner ear infection.  continuing to have dizziness and some ear pain.
admitted to hospital 7/29/2021 until 8/06/2021 Then readmitted 08/09/2021. As of today 8/13, he was in rehab unit and expected to be discharged on Sunday 08/15/2021
This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. On 10-JAN-2019, the patient was vaccinated with one dose of improperly stored ROTATEQ lot # R016271, expiry date 25-MAY-2020, oral (dose number was not reported) for prophylaxis. The temperature excursion and time frame were not reported. There was no previous temperature excursion. No adverse effects were reported.
she fell when she came home; tested positive for COVID; tested positive for COVID; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient fell when she came home and had to go to the hospital when she was there she tested positive for COVID, the patient had the first dose of the vaccine then tested positive for COVID. Her next shot was due on 02Apr2021 (Friday). The outcome was unknown.  Information about Lot/Batch number is requested.
2 days after developed extreme fatigue and headache, next day developed nausea, vomiting, and diarrhea, within the next 24 hours developed a rash to face and body that was red and very itchy.  The next day headache became unbearable and nothing would relieve it. over the next few months I developed severe hot flashes and night sweats. also in the last few months have had "brain zaps" that radiate through body and continuation of headaches and fatigue.
TIRED; This spontaneous report received from a consumer concerned a 69 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient had no medical conditions. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 02-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. Concomitant medications included estrogens conjugated.  On 02-APR-2021, the patient experienced tired. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from tired on 02-APR-2021. This report was non-serious. This case, from the same reporter is linked to 20220110118.
Patient did not receive here but came to the pharmacy asking for advice. She experienced intense itching and described feeling like she was sunburned after second dose but also reported experiencing the same side effects after the first dose of SHINGRIX - adverse effects lingered for 3 weeks.
24 hours: headache, fatigue. 48 hours: body ache, fatigue. 72 hours: rash and hives at injection site, across upper chest and covering neck. 96 hours: fatigue, low-grade fever. 120 hours: dizziness, vomiting, very sick. 144 hours: sore, tired slept ? ditto for 168 hours. 192 hours: dizzy again.
Hives; This spontaneous case was reported by a nurse and describes the occurrence of URTICARIA (Hives) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced URTICARIA (Hives). At the time of the report, URTICARIA (Hives) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment information were reported.
Started with flushing. Recieved 25mg Bendaryl po, which did not seem to help. progressed to nausea, some SOB, received epi, then started to break out. Prepare to take to BMC. Another dose of epi was given prior to transport. BP 176/106 HR 84 P 22
The patient has flu like symptoms, rash on left arm, stiff neck. Side effects started showing up on 7/12, about 20 hours after the injections. We were notified at 48 hours after the injections.
Pt started with (L) arm pain at injection site, that kept him up at night after receiving BEXSERO vaccine. Pain lasted for 2 days. (L) upper arm swollen 1 day after receiving vaccine. Patient presents in office on 3/6/18 w/(R) upper arm at 12cm redness, swelling, warm to touch. Pt prescribed AUGMENTIN Rx.
Pt states she feels throat tightness after receiving vaccine. States she is allergic to shellfish and feels same. States she had to go to ER for epi shot 2 years ago due to shellfish reaction. Pt states throat tightness does not interfere with breathing and is feeling better after 30 minutes. No epi given. tightness resolved at 15:12.